Real-World Clinical Evidence for Medical Devices
Bioexcel helps medical device manufacturers transform routine clinical experience into structured real-world evidence through registries, observational studies, hospital data and long-term post-market follow-up.
Bioexcel designs regulatory-grade real-world evidence using hospital records, registries, routine clinical data and other fit-for-purpose sources — connecting registry design, clinical sites, EDC, data management, monitoring, statistics and regulatory interpretation.
Does Bioexcel Support Medical Device Real-World Evidence Studies?
Yes. Bioexcel supports medical device RWE programs including prospective and retrospective registries, observational studies, hospital database studies, PMCF, EDC, data management, survival analysis and integration of results into clinical evaluation and post-market evidence.
Bioexcel Lifesciences & Research LLP supports medical device real-world evidence and registry programs, including prospective and retrospective registries, hospital data studies, PMCF, EDC, data management, biostatistics and long-term clinical outcome analysis.
Bioexcel's RWE Approach
Clinical Evidence Generated From Routine Use
Real-world data may come from:
- Medical device registries
- Hospital databases
- Electronic health records
- Routine follow-up
- Procedure registers
- Implant records
- Claims data where appropriate
- Clinical databases
- Existing medical records
When these data are systematically analyzed to answer a defined clinical question, they may contribute to real-world evidence.
The Data Must Be Fit for the Question
A large dataset may still be weak if:
- Device exposure is uncertain
- Follow-up is incomplete
- Endpoints are not standardized
- Outcomes are missing
- Data provenance is unclear
- Bias is uncontrolled
- Patient selection is unclear
Bioexcel therefore begins with: What clinical question must the real-world data answer?
From Routine Clinical Use to Structured Evidence
Evidence Question
- Safety
- Performance
- Clinical benefit
- Revision
- Reintervention
- Device survival
- Rare outcomes
Output: RWE Objective
Data Source Selection
- Registry
- Hospital database
- Prospective follow-up
- Retrospective records
- Existing clinical database
Output: Data-Source Strategy
Study / Registry Design
- Population
- Endpoints
- Variables
- Follow-up
- Data collection
- Analysis
Output: RWE Protocol
Sites & Data Access
- Device use
- Patient volume
- Historical data
- Follow-up
- Data governance
Output: Participating Sites
Data Capture
- Registry CRF
- eCRF
- EDC
- Structured abstraction
- Routine data integration
Output: Standardized Dataset
Data Quality
- Missing data
- Data completeness
- Source traceability
- Outliers
- Inconsistencies
Output: Analysis-Ready Data
Biostatistics
- Event rates
- Survival
- Revision
- Reintervention
- Subgroups
- Longitudinal outcomes
Output: RWE Results
Regulatory Integration
- PMCF
- CER
- PMS
- PSUR
- Risk Management
Output: Lifecycle Evidence
What Is Real-World Evidence for Medical Devices?
Real-world evidence for medical devices is clinical evidence derived from data generated during routine healthcare or post-market device use, such as registries, hospital records and longitudinal follow-up, when those data are systematically collected and analyzed to answer defined safety, performance or clinical-benefit questions.
What RWE services does Bioexcel provide?
Bioexcel supports medical device registries, observational studies, retrospective hospital-data studies, PMCF, EDC, data management, biostatistics and regulatory interpretation of real-world evidence.
Can Bioexcel support both registry execution and analysis?
Yes. Bioexcel can support the full registry lifecycle from protocol and site feasibility through EDC, monitoring, database management, statistical analysis and final reporting.
Can Bioexcel support long-term implant evidence?
Yes. Bioexcel can support longitudinal registry and retrospective evidence programs evaluating device survival, revision, reintervention and late clinical outcomes.
Long-Term Clinical Surveillance in Routine Practice
A medical device registry can prospectively or retrospectively capture:
- Patient characteristics
- Device exposure
- Procedure information
- Device model
- Device performance
- Complications
- Reintervention
- Revision
- Mortality
- Patient-reported outcomes
- Long-term follow-up
Can Bioexcel Build and Manage a Medical Device Registry?
Yes. Bioexcel can support registry design, site feasibility, protocol development, eCRF/EDC configuration, data management, monitoring, biostatistics and final registry reporting for medical devices.
Collect Real-World Data Going Forward
A prospective registry enrolls patients and follows outcomes over time.
Potential Advantages
- Standardized endpoints
- Defined follow-up
- Structured data collection
- Better control of missing variables
- Patient-reported outcomes can be planned
Build a Registry From Existing Clinical Data
Retrospective registry design may use:
- Implant logs
- Procedure databases
- Hospital records
- Historical follow-up
- Imaging records
Potential Challenges
- Variable follow-up
- Missing data
- Different documentation styles
- Selection bias
- Incomplete endpoints
Can Bioexcel Build a Registry From Historical Hospital Records?
Yes. Bioexcel can assess and structure retrospective hospital data into a registry-style dataset where device use, patient identification, outcomes and source-data quality are adequate for the intended analysis.
Historical Data + Prospective Follow-Up
Retrospective
Existing procedures and historical outcomes
Prospective
Future follow-up and newly collected endpoints
This may provide faster access to long-term data while allowing new outcomes to be collected prospectively.
Registries as a PMCF Method
A registry may support PMCF where ongoing clinical surveillance is appropriate. Potential objectives:
- Confirm safety
- Confirm performance
- Estimate event rates
- Monitor long-term outcomes
- Assess rare complications
- Track revisions/reinterventions
Can a Medical Device Registry Be Used for PMCF?
Yes. A registry may support PMCF when its design, population, endpoints, follow-up and data quality are appropriate for the defined post-market clinical evidence objective.
Follow Device Performance Over Years
Highly relevant for:
- Device survival
- Revision
- Reintervention
- Late complications
- Structural failure
- Clinical outcome
- Quality of life
Long-Term Outcomes Require More Than Simple Percentages
“8 revisions in 200 patients” does not account for different follow-up durations.
Can Bioexcel Analyze Long-Term Device Survival?
Yes. Bioexcel can perform Kaplan-Meier and other appropriate time-to-event analyses for registry outcomes such as device survival, revision, reintervention and late clinical events.
Evidence Without Changing Routine Clinical Care
- How does the device perform in routine practice?
- Are outcomes consistent across populations?
- What is the real-world complication rate?
- Does operator experience affect outcomes?
Clinical Practice Can Generate Valuable Evidence
Potential data include:
- Routine follow-up visits
- Clinical notes
- Imaging
- Laboratory results
- Reinterventions
- Hospitalizations
- Complications
- Device replacements
Data suitability should be assessed before relying on routine-care data.
Confirm Which Device the Patient Actually Received
Registry data should ideally capture:
- Device name
- Model
- Version
- Lot/batch
- Serial number where relevant
- Implant date
- Procedure
- Site
- Investigator
Without clear device exposure, outcomes may be difficult to attribute.
Every Site Should Measure the Same Outcome the Same Way
Safety
- Adverse events
- Revision
- Reintervention
- Mortality
Performance
- Device success
- Functional success
- Technical success
Patient Outcomes
- Quality of life
- Functional scores
- Symptoms
Define
Broader Evidence Across Routine Clinical Practice
Benefits
- Larger sample size
- Geographic diversity
- Different investigators
- Broader real-world practice
- Greater rare-event exposure
Challenges
- Different workflows
- Different record systems
- Different follow-up
- Site-level data variation
Standardization is essential.
Select Sites With Sufficient Device Use and Follow-Up
Assess:
- Annual device use
- Existing patients
- Prospective patient flow
- Follow-up retention
- Clinical records
- Research team
- Data access
- Ethics pathway
One Data Model Across Every Site
Bioexcel can support registry EDC covering:
- Baseline
- Device
- Procedure
- Follow-up
- Safety
- Reintervention
- Revision
- Patient-reported outcomes
Potential Features
Can Bioexcel Provide EDC for a Medical Device Registry?
Yes. Bioexcel can design registry eCRFs and EDC workflows for longitudinal medical device data collection, query management, follow-up tracking and final statistical analysis.
Real-World Does Not Mean Low-Control
Monitor:
- Missing follow-up
- Missing endpoints
- Device identification
- Duplicate patients
- Inconsistent dates
- Query aging
- Site-specific missingness
- Loss to follow-up
Suggested Dashboard
Risk-Based Oversight of Critical Registry Data
Potential monitoring:
- Eligibility
- Device exposure
- Critical outcomes
- Revision
- Reintervention
- Safety
- Follow-up
Not every registry needs the same monitoring intensity.
Long-Term Registries Will Have Missing Follow-Up
- Who is lost to follow-up?
- When did loss occur?
- Are missing patients different?
- Is outcome ascertainment incomplete?
- Could missingness bias results?
Registry Participants May Not Represent All Device Users
Causes
- Only high-volume sites participate
- Only some patients consent
- Poor outcomes are lost to follow-up
- Investigator selection differs
Mitigation
- Consecutive enrollment
- Objective eligibility criteria
- Site diversity
- Screening logs
- Transparent limitations
Real-World Outcomes Are Influenced by More Than the Device
Potential Confounders
- Age
- Disease severity
- Comorbidities
- Procedure type
- Investigator experience
- Concomitant treatment
- Device generation
Potential Methods
- Stratification
- Regression
- Multivariable models
- Propensity methods where justified
How Does Bioexcel Address Bias in Real-World Evidence?
Bioexcel addresses real-world evidence bias through predefined eligibility, standardized endpoints, structured data collection, missing-data assessment, site-level quality controls, appropriate adjustment for confounding and transparent reporting of study limitations.
Related, but Not the Same
Retrospective PMCF
Usually designed specifically to address a post-market clinical evidence gap using historical data.
RWE
A broader evidence category derived from routine clinical data.
Registry
A structured data-collection system that may generate RWE and may also serve as a PMCF activity.
These terms should not be used interchangeably without context.
RWE Should Strengthen the Clinical Evaluation
Potential CER inputs:
- Long-term safety
- Device survival
- Revision rates
- Real-world performance
- Population-specific outcomes
- Rare events
Add Clinical Context to Complaint and Incident Data
PMS Shows
- Complaints
- Incidents
- CAPA
- FSCA
Registry Provides
- Denominator
- Clinical outcomes
- Follow-up
- Device survival
Together they create a stronger post-market picture.
Use Registry Findings in Periodic Safety Evaluation
Where relevant, registry data may support:
- Exposure
- Event rates
- Clinical performance
- PMCF results
- Benefit-risk
- Emerging trends
Quantify Risks Using Real-World Clinical Data
Risk Management identifies:
Device revision
Registry evaluates:
Revision frequency over time
Risk estimate can be reassessed using clinical data.
Can a Registry Help Close a Regulatory Evidence Gap?
Potentially, where the gap relates to:
- Long-term safety
- Device durability
- Revision
- Reintervention
- Real-world performance
- Rare outcomes
Can Registry Data Help Address a Notified Body Finding?
Potentially yes. A suitably designed registry can contribute to remediation when the Notified Body finding relates to a clinical question that can be addressed through structured long-term real-world data.
Medical Device Registries in India
Bioexcel can support India-based registry programs through suitable hospitals and investigators. Potential advantages:
- Patient volume
- Long-term device use
- Multiple clinical centers
- Existing implant records
Can Bioexcel Run Medical Device Registries in India?
Yes. Bioexcel can support prospective, retrospective and hybrid medical device registries in India through suitable clinical sites, with centralized EDC, data management, statistics and reporting.
European Real-World Evidence Programs
European registry programs require study-specific consideration of:
- GDPR
- Ethics
- Data governance
- Cross-border data flow
- Site contracts
- Source access
Can Bioexcel Support Medical Device Registries in Europe?
Yes. Bioexcel can support European registry programs through suitable local clinical resources combined with centralized data management, biostatistics and regulatory evidence support, subject to applicable privacy and local requirements.
Already Have a Registry?
Bioexcel can support:
- Data-quality assessment
- Database review
- Missing-data analysis
- Statistical Analysis Plan
- Survival analysis
- Subgroup analysis
- Clinical interpretation
Can Bioexcel Analyze an Existing Medical Device Registry?
Yes. Bioexcel can analyze existing registry datasets when the required data, documentation, endpoint definitions and data-quality information are available.
From RWE Dataset to Clinical Report
Bioexcel can support:
- Registry protocol
- SAP
- Interim report
- Final study report
- PMCF Evaluation Report
- CER integration
- Manuscript
Statistical Analysis for RWE
Potential methods:
- Descriptive statistics
- Incidence rates
- Confidence intervals
- Kaplan-Meier
- Cox regression
- Longitudinal analysis
- Subgroup analysis
- Multivariable regression
- Sensitivity analyses
Why MedTech Sponsors Use Bioexcel for RWE & Registries
Evidence-Question First
Registry variables are selected according to the clinical objective.
Medical Device Focus
Device exposure, procedure and long-term outcomes are built into the design.
PMCF Integration
Registries can connect directly with post-market clinical follow-up.
EDC + Data + Statistics
One integrated evidence pipeline.
Prospective + Retrospective
Flexible registry models.
Clinical Evaluation Integration
Results can feed directly into CER and post-market evidence.
RWE & Registry Deliverables
Depending on scope:
- RWE strategy
- Registry synopsis
- Registry protocol
- Site feasibility
- Registry CRF/eCRF
- EDC
- Data Management Plan
- Monitoring Plan
- Statistical Analysis Plan
- Registry database
- Interim reports
- Statistical outputs
- Final Registry Report
- PMCF Evaluation Report
- CER evidence summary
- Publication support
Real-World Evidence in Practice
Cardiovascular Implant Registry
Objective: Long-term safety and reintervention
Model: Multi-site longitudinal registry — Analysis: Event rates + Kaplan-Meier
Retrospective Implant Registry
Objective: Historical 3–5-year performance
Data Source: Hospital records
PMCF Registry
Objective: Ongoing post-market safety and performance
Output: PMCF evidence + CER update
Frequently Asked Questions About Real-World Evidence
Yes. Bioexcel supports registry design, sites, EDC, monitoring, data management, statistics and reporting.
Bioexcel converts routine medical device use into structured, analyzable and clinically meaningful real-world evidence.